References

1. Brachman P, Friedlander AM. Vaccines. In: Plotkin SA, Orenstein WA. Anthrax. Philadelphia: WB Saunders; 1999:629-37.

2. CDC. Bioterrorism alleging use of anthrax and interim guidelines for management--United States, 1998. MMWR Morb Mortal Wkly Rep. Feb 5 1999;48(4):69-74. [Medline].

3. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM. Biological warfare. A historical perspective. JAMA. Aug 6 1997;278(5):412-7. [Medline].

4. Cieslak TJ, Eitzen EM. Clinical and epidemiologic principles of anthrax. Emerg Infect Dis. Jul-Aug 1999;5(4):552-5. [Medline].

5. Cunha BA. Doxycycline re-revisited. Arch Intern Med. May 10 1999;159(9):1006-7. [Medline].

6. Cunha BA. Doxycycline. Antibiotics for Clinicians. Vol 3. 1999:21-33.

7. Cunha BA, Domenico P, Cunha CB. Pharmacodynamics of doxycycline. Clin Microbiol Infect. May 2000;6(5):270-3. [Medline].

8. Cunha CB. Anthrax: Ancient Plague, Persistent Problem. Infect Dis Pract. 1999;23(4).

9. Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med. Sep 9 1999;341(11):815-26. [Medline].

10. Dragon DC, Rennie RP. The ecology of anthrax spores: tough but not invincible. Can Vet J. May 1995;36(5):295-301. [Medline].

11. Friedlander AM. Anthrax: clinical features, pathogenesis, and potential biological warfare threat. Curr Clin Top Infect Dis. 2000;20:335-49. [Medline].

12. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. May 12 1999;281(18):1735-45. [Medline].

13. Kadlec RP, Zelicoff AP, Vrtis AM. Biological weapons control. Prospects and implications for the future. JAMA. Aug 6 1997;278(5):351-6. [Medline].

14. Lalitha MK, Mathai D, Thomas K. Anthrax: a continuing problem in southern India. Salisbury Med Bull Suppl. 1996;87:14-15.

15. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A. The Sverdlovsk anthrax outbreak of 1979. Science. Nov 18 1994;266(5188):1202-8. [Medline].

16. Office of the Surgeon General. Medical aspects of chemical and biological warfare. Washington, DC: US Dept of the Army; 1997:467.

17. Pile JC, Malone JD, Eitzen EM, Friedlander AM. Anthrax as a potential biological warfare agent. Arch Intern Med. Mar 9 1998;158(5):429-34. [Medline].

18. Plotkin SA, Brachman PS, Utell M. An epidemic of inhalation anthrax, the first in the twentieth century. Am J Med. 1960;29.

19. Shlyakhov E, Rubinstein E. Evaluation of the anthraxin skin test for diagnosis of acute and past human anthrax. Eur J Clin Microbiol Infect Dis. Mar 1996;15(3):242-5. [Medline].

20. Shlyakhov EN, Rubinstein E. Human live anthrax vaccine in the former USSR. Vaccine. Jun 1994;12(8):727-30. [Medline].

21. Stepanov AV, Marinin LI, Pomerantsev AP, Staritsin NA. Development of novel vaccines against anthrax in man. J Biotechnol. Jan 26 1996;44(1-3):155-60. [Medline].